Our formulation development scientists focus on both generic as well as NCE formulations, which fulfill regulatory requirements of targeted markets, possess attributes sought after by medical practitioners and meet customer’s performance metrics.
We adopt a comprehensive, time-bound strategy in developing stable products that are efficient in all quality aspects. We work on our development strategy based on in-depth study of patents, scientific literature, compendia information, critical quality attributes (CQA) and quality target product profiles (QTPP) of the respective drug delivery system and nature of the molecule.
We develop optimised processes that ensure smooth commercial manufacturing. We are sensitive in utilising the client investments/budgets to deliver a cost-effective solution for their formulation development needs. We help pharmaceutical companies to successfully resolve their challenging pharmaceutical compounds both in early-phase formulation development and as well as full generic development.